133 related articles for article (PubMed ID: 3371190)
21. Lopinavir protein binding in vivo through the 12-hour dosing interval.
Boffito M; Hoggard PG; Lindup WE; Bonora S; Sinicco A; Khoo SH; Di Perri G; Back DJ
Ther Drug Monit; 2004 Feb; 26(1):35-9. PubMed ID: 14749547
[TBL] [Abstract][Full Text] [Related]
22. Alteration of vancomycin pharmacokinetics during cardiopulmonary bypass in patients undergoing cardiac surgery.
Ortega GM; Martí-Bonmatí E; Guevara SJ; Gómez IG
Am J Health Syst Pharm; 2003 Feb; 60(3):260-5. PubMed ID: 12613235
[TBL] [Abstract][Full Text] [Related]
23. Binding parameters of valproic acid to serum protein in healthy adults at steady state.
Kodama Y; Koike Y; Kimoto H; Yasunaga F; Takeyama M; Teraoka I; Fujii I
Ther Drug Monit; 1992 Feb; 14(1):55-60. PubMed ID: 1546390
[TBL] [Abstract][Full Text] [Related]
24. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
25. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
Barré J; Chamouard JM; Houin G; Tillement JP
Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
[TBL] [Abstract][Full Text] [Related]
26. The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration.
Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum A; 1989; 40(7):629-35. PubMed ID: 2551860
[TBL] [Abstract][Full Text] [Related]
27. Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.
Monaghan MS; Marx MA; Olsen KM; Turner PD; Bergman KL
Ther Drug Monit; 2001 Jun; 23(3):263-7. PubMed ID: 11360036
[TBL] [Abstract][Full Text] [Related]
28. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.
Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J
J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461
[TBL] [Abstract][Full Text] [Related]
29. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
30. Factors impacting unbound vancomycin concentrations in neonates and young infants.
Smits A; Pauwels S; Oyaert M; Peersman N; Spriet I; Saegeman V; Allegaert K
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1503-1510. PubMed ID: 29770901
[TBL] [Abstract][Full Text] [Related]
31. Variability in teicoplanin protein binding and its prediction using serum albumin concentrations.
Yano R; Nakamura T; Tsukamoto H; Igarashi T; Goto N; Wakiya Y; Masada M
Ther Drug Monit; 2007 Aug; 29(4):399-403. PubMed ID: 17667792
[TBL] [Abstract][Full Text] [Related]
32. Removal of vancomycin during plasmapheresis.
McClellan SD; Whitaker CH; Friedberg RC
Ann Pharmacother; 1997 Oct; 31(10):1132-6. PubMed ID: 9337436
[TBL] [Abstract][Full Text] [Related]
33. Effect of ultrafiltrate volume on determination of free phenytoin concentration.
McMillin GA; Juenke J; Dasgupta A
Ther Drug Monit; 2005 Oct; 27(5):630-3. PubMed ID: 16175137
[TBL] [Abstract][Full Text] [Related]
34. Protein binding of aspirin and salicylate measured by in vivo ultrafiltration.
Ghahramani P; Rowland-Yeo K; Yeo WW; Jackson PR; Ramsay LE
Clin Pharmacol Ther; 1998 Mar; 63(3):285-95. PubMed ID: 9542472
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an automated fluorescence polarization immunoassay for vancomycin.
Filburn BH; Shull VH; Tempera YM; Dick JD
Antimicrob Agents Chemother; 1983 Aug; 24(2):216-20. PubMed ID: 6357070
[TBL] [Abstract][Full Text] [Related]
36. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.
Gugler R; Mueller G
Br J Clin Pharmacol; 1978 May; 5(5):441-6. PubMed ID: 350249
[TBL] [Abstract][Full Text] [Related]
37. Disposition of vancomycin during hemofiltration.
Matzke GR; O'Connell MB; Collins AJ; Keshaviah PR
Clin Pharmacol Ther; 1986 Oct; 40(4):425-30. PubMed ID: 3757406
[TBL] [Abstract][Full Text] [Related]
38. Binding of radioiodinated human beta-endorphin to serum proteins from rats and humans, determined by several methods.
Sato H; Sugiyama Y; Sawada Y; Iga T; Hanano M
Life Sci; 1985 Oct; 37(14):1309-18. PubMed ID: 2931565
[TBL] [Abstract][Full Text] [Related]
39. Determination of protein binding of a highly lipophilic drug, isocarbacyclin methyl ester (TEI-9090), using a polydimethylsiloxane-coated glass beads assay.
Minagawa T; Kohno Y; Suwa T; Tsuji A
J Pharm Pharmacol; 1994 Oct; 46(10):838-43. PubMed ID: 7699573
[TBL] [Abstract][Full Text] [Related]
40. Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.
Ackerman BH; Berg HG; Strate RG; Rotschafer JC
J Clin Microbiol; 1983 Oct; 18(4):994-5. PubMed ID: 6630478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]